2017 Q1 Form 10-Q Financial Statement

#000114420417027519 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q1
Revenue $14.61M $2.044M
YoY Change 614.73% 1262.67%
Cost Of Revenue $8.934M $1.847M
YoY Change 383.7%
Gross Profit $5.675M $197.0K
YoY Change 2780.71% 31.33%
Gross Profit Margin 38.85% 9.64%
Selling, General & Admin $4.993M $2.952M
YoY Change 69.14% -1.53%
% of Gross Profit 87.98% 1498.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.726M $850.0K
YoY Change 103.06% 6.25%
% of Gross Profit 30.41% 431.47%
Operating Expenses $4.993M $2.952M
YoY Change 69.14% -1.53%
Operating Profit -$4.569M -$3.606M
YoY Change 26.71% -46.6%
Interest Expense $189.0K $476.0K
YoY Change -60.29%
% of Operating Profit
Other Income/Expense, Net -$78.00K -$349.0K
YoY Change -77.65% 56.5%
Pretax Income -$4.644M -$3.955M
YoY Change 17.42% -43.31%
Income Tax $227.0K $0.00
% Of Pretax Income
Net Earnings -$6.425M -$3.955M
YoY Change 62.45% -43.31%
Net Earnings / Revenue -43.98% -193.49%
Basic Earnings Per Share -$0.34 -$0.28
Diluted Earnings Per Share -$0.34 -$0.28
COMMON SHARES
Basic Shares Outstanding 18.86M shares 14.16M shares
Diluted Shares Outstanding 18.86M shares 14.16M shares

Balance Sheet

Concept 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.70M $20.60M
YoY Change -43.2% 68.85%
Cash & Equivalents $11.67M $20.56M
Short-Term Investments
Other Short-Term Assets $1.379M $1.800M
YoY Change -23.39% 362.72%
Inventory $2.918M $475.0K
Prepaid Expenses $439.0K
Receivables $1.700M $1.060M
Other Receivables $0.00 $0.00
Total Short-Term Assets $17.70M $23.40M
YoY Change -24.38% 59.21%
LONG-TERM ASSETS
Property, Plant & Equipment $16.23M
YoY Change
Goodwill $27.49M
YoY Change
Intangibles $15.49M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.330M $900.0K
YoY Change 47.78% -9.0%
Total Long-Term Assets $61.01M $21.50M
YoY Change 183.75% 20.72%
TOTAL ASSETS
Total Short-Term Assets $17.70M $23.40M
Total Long-Term Assets $61.01M $21.50M
Total Assets $78.70M $44.90M
YoY Change 75.28% 38.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.50M $3.700M
YoY Change 183.78% -22.92%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.80M $3.700M
YoY Change 191.89% -22.11%
LONG-TERM LIABILITIES
Long-Term Debt $6.500M $600.0K
YoY Change 983.33%
Other Long-Term Liabilities $1.000M $152.0K
YoY Change 557.89% -89.91%
Total Long-Term Liabilities $6.500M $152.0K
YoY Change 4176.32% -89.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.80M $3.700M
Total Long-Term Liabilities $6.500M $152.0K
Total Liabilities $18.37M $4.900M
YoY Change 274.8% -21.69%
SHAREHOLDERS EQUITY
Retained Earnings -$227.3M -$200.8M
YoY Change 13.18% 4.22%
Common Stock $150.0K
YoY Change -83.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $55.62M $40.02M
YoY Change
Total Liabilities & Shareholders Equity $78.70M $44.88M
YoY Change 75.38% 38.04%

Cashflow Statement

Concept 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$6.425M -$3.955M
YoY Change 62.45% -43.31%
Depreciation, Depletion And Amortization $1.726M $850.0K
YoY Change 103.06% 6.25%
Cash From Operating Activities -$4.899M -$5.429M
YoY Change -9.76% 55.03%
INVESTING ACTIVITIES
Capital Expenditures $808.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$130.0K $1.170M
YoY Change -111.11% -517.86%
Cash From Investing Activities -$933.0K $1.087M
YoY Change -185.83% -491.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$361.0K -$50.00K
YoY Change 622.0%
NET CHANGE
Cash From Operating Activities -$4.899M -$5.429M
Cash From Investing Activities -$933.0K $1.087M
Cash From Financing Activities -$361.0K -$50.00K
Net Change In Cash -$6.193M -$4.392M
YoY Change 41.01% 16.19%
FREE CASH FLOW
Cash From Operating Activities -$4.899M -$5.429M
Capital Expenditures $808.0K $0.00
Free Cash Flow -$5.707M -$5.429M
YoY Change 5.12% 55.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Technology Services Revenue
TechnologyServicesRevenue
1294000 USD
CY2017Q1 us-gaap Goodwill
Goodwill
27486000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
25166000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
449000 USD
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1379000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2242000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
17696000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
23544000 USD
CY2017Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15488000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15610000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1330000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1382000 USD
CY2017Q1 us-gaap Assets
Assets
78702000 USD
CY2016Q4 us-gaap Assets
Assets
82807000 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11630000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11773000 USD
CY2017Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000 USD
CY2017Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6500000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227293000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220868000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
78702000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82807000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
2918000 USD
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
476000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
638000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16226000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
328000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
143000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
18365000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000 USD
CY2017Q1 us-gaap Minority Interest
MinorityInterest
4717000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
4641000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
55620000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
18638000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
59528000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1899000 USD
CY2017Q1 fh Wellness Services Revenue
WellnessServicesRevenue
10984000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64169000 USD
CY2017Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60337000 USD
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6500000 USD
CY2017Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6860000 USD
CY2016Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2952000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
20653000 USD
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
5650000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6044000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3606000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
111000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
337000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6122000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3955000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
227000 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18862715 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14158680 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18862715 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14158680 shares
CY2017Q1 us-gaap Interest Expense
InterestExpense
189000 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
476000 USD
CY2017Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
0 USD
CY2016Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
210000 USD
CY2017Q1 us-gaap Revenues
Revenues
14609000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-6349000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-3955000 USD
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-44000 USD
CY2016Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6393000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3955000 USD
CY2017Q1 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
76000 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
741000 USD
CY2016Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40020000 USD
CY2016Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
463000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40516000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
463000 USD
CY2016Q1 fh Fair Value Of Derivative Warrant Liabilities And Conversion Feature
FairValueOfDerivativeWarrantLiabilitiesAndConversionFeature
-11000 USD
CY2016Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
86000 USD
CY2016Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-239000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2490000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5429000 USD
CY2016Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
-1173000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1087000 USD
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
814000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
96000 USD
CY2016Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
193000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4391000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24951000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20560000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-50000 USD
CY2016Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000 USD
CY2016Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-356000 USD
CY2016Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
414000 USD
CY2017Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
741000 USD
CY2017Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
11000 USD
CY2016Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2017Q1 fh Fair Value Of Derivative Warrant Liabilities And Conversion Feature
FairValueOfDerivativeWarrantLiabilitiesAndConversionFeature
26000 USD
CY2017Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2017Q1 us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
-1121000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1693000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4899000 USD
CY2017Q1 us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-933000 USD
CY2017Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-361000 USD
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-44000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6237000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
742000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-76000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
65000 USD
CY2017Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2000 USD
CY2016Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-234000 USD
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12901967 shares
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2213707 shares
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
FORM Holdings Corp.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001410428
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
FH
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19565531 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19198454 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18304881 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19198454 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18304881 shares
CY2017Q1 us-gaap Technology Services Revenue
TechnologyServicesRevenue
3525000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.39
CY2016Q1 fh Wellness Services Revenue
WellnessServicesRevenue
0 USD
CY2017Q1 us-gaap Technology Services Costs
TechnologyServicesCosts
2960000 USD
CY2016Q1 us-gaap Technology Services Costs
TechnologyServicesCosts
1127000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
11894000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
1847000 USD
CY2017Q1 fh Wellness Services Costs
WellnessServicesCosts
8835000 USD
CY2016Q1 fh Wellness Services Costs
WellnessServicesCosts
0 USD
CY2017Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1809000 USD
CY2017Q1 fh Amendment To Warrants As Part Of Debt Modification
AmendmentToWarrantsAsPartOfDebtModification
0 USD
CY2016Q1 fh Amendment To Warrants As Part Of Debt Modification
AmendmentToWarrantsAsPartOfDebtModification
-281000 USD
CY2017Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
26000 USD
CY2016Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
895000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2017Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
64000 USD
CY2016Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
86000 USD
CY2017Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
361000 USD
CY2016Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
CY2017Q1 fh Conversion Original Debt And Interest Amount
ConversionOriginalDebtAndInterestAmount
0 USD
CY2016Q1 fh Conversion Original Debt And Interest Amount
ConversionOriginalDebtAndInterestAmount
2996000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
69001 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
16368 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5138732 shares
CY2017Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">(b) Use of estimates</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">&#160;</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the accompanying condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company&#8217;s intangible assets, the useful lives of the Company&#8217;s intangible assets, the valuation of the Company&#8217;s derivative warrants, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i><font style="FONT-SIZE: 10pt">(g) Reclassification</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><b><i><font style="FONT-SIZE: 10pt"> &#160;</font></i></b></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain balances have been reclassified to conform to presentation requirements, including consistent presentation of cost of sales and general and administrative expenses to align presentation for operating segments.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-78000 USD
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-349000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3679101 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1545000 shares
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2028941 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.60
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.12
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
25.92
CY2017Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
43.66
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.59
CY2017Q1 fh Working Capital Deficit Excluding Cash And Cash Equivalents
WorkingCapitalDeficitExcludingCashAndCashEquivalents
79000 USD
CY2016Q1 fh Working Capital Deficit Excluding Cash And Cash Equivalents
WorkingCapitalDeficitExcludingCashAndCashEquivalents
0 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
5.41
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.93
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
17.58
CY2017Q1 fh Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue
22.02
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.85
CY2017Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
2125000 USD
CY2017Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
888573 shares
CY2017Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
316000 USD
CY2017Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1809000 USD
CY2017Q1 us-gaap Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
227000 USD
CY2017Q1 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
to the former stockholders of Excalibur (the Excalibur Sellers). In addition, the Excalibur Sellers will, in the three years following the closing of this transaction, also receive $500 for each $2,000 of gross profit generated by a specified list of Excalibur accounts annually, until such cumulative gross profit reaches $6,000, and an additional $500 when such cumulative profit reaches $10,000, such amounts are payable in either cash or the Companys common stock, at the election of the Company.
CY2017Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
26000 USD
CY2017Q1 us-gaap Royalty Revenue
RoyaltyRevenue
100000 USD
CY2016Q1 us-gaap Royalty Revenue
RoyaltyRevenue
750000 USD
CY2017Q1 us-gaap Royalty Expense
RoyaltyExpense
99000 USD
CY2016Q1 us-gaap Royalty Expense
RoyaltyExpense
720000 USD
CY2017Q1 us-gaap Interest Paid
InterestPaid
150000 USD
CY2017Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
21000 USD
CY2016Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2017Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
556000 USD
CY2016Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 USD
CY2017Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
2320000 USD
CY2016Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2017Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
29000 USD
CY2016Q1 us-gaap Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
0 USD
CY2017Q1 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
361000 USD
CY2016Q1 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
0 USD
CY2017Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
387000 USD
CY2016Q1 us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
0 USD
CY2017Q1 us-gaap Stock Issued1
StockIssued1
1809000 USD
CY2016Q1 us-gaap Stock Issued1
StockIssued1
0 USD
CY2017Q1 fh Non Cash Or Part Non Cash Acquisition Fair Value Of Contingent Liability
NonCashOrPartNonCashAcquisitionFairValueOfContingentLiability
316000 USD
CY2016Q1 fh Non Cash Or Part Non Cash Acquisition Fair Value Of Contingent Liability
NonCashOrPartNonCashAcquisitionFairValueOfContingentLiability
0 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6425000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3955000 USD
CY2017Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 1. General</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">FORM Holdings Corp. (&#8220;FORM&#8221; or the &#8220;Company&#8221;) is a holding company of small to middle market growth companies.&#160;The Company has three operating segments: wellness, technology and intellectual property.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company&#8217;s wellness operating segment consists of XpresSpa, which is a leading airport retailer of spa services. XpresSpa is a well-recognized airport spa brand with 53 locations in 40 terminals and 22 airports in the United States, Netherlands, and United Arab Emirates.&#160;XpresSpa offers travelers premium spa services, including massage, nail and hair as well as spa and travel products. The Company acquired XpresSpa in the fourth quarter of 2016.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s technology operating segment consists of Group Mobile and FLI Charge as well as an <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% equity interest in InfoMedia Services Limited (&#8220;InfoMedia&#8221;).&#160;Group Mobile offers rugged hardware and software solutions, including laptops, tablets, and mobile printers, as well as installation and deployment services. FLI Charge offers wireless conductive charging and power solutions for electronic devices. The Company acquired Group Mobile and FLI Charge in the fourth quarter of 2015 and Excalibur Integrated Systems Inc. (&#8220;Excalibur&#8221;), which was merged with Group Mobile, in the first quarter of 2017. The Company&#8217;s equity interest in InfoMedia increased from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8.25</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% in the first quarter of 2017 due to a realignment of ownership interests.<b>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></b></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="justify">The Company&#8217;s intellectual property operating segment is engaged in the monetization of patents related to content and ad delivery, remote monitoring and mobile technologies.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
11000 USD
CY2016Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2996000 USD
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0727 pure

Files In Submission

Name View Source Status
0001144204-17-027519-index-headers.html Edgar Link pending
0001144204-17-027519-index.html Edgar Link pending
0001144204-17-027519.txt Edgar Link pending
0001144204-17-027519-xbrl.zip Edgar Link pending
fh-20170331.xml Edgar Link completed
fh-20170331.xsd Edgar Link pending
fh-20170331_cal.xml Edgar Link unprocessable
fh-20170331_def.xml Edgar Link unprocessable
fh-20170331_lab.xml Edgar Link unprocessable
fh-20170331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v466214_10q.htm Edgar Link pending
v466214_ex10-1.htm Edgar Link pending
v466214_ex10-2.htm Edgar Link pending
v466214_ex10-3.htm Edgar Link pending
v466214_ex10-4.htm Edgar Link pending
v466214_ex10-5.htm Edgar Link pending
v466214_ex31-1.htm Edgar Link pending
v466214_ex31-2.htm Edgar Link pending
v466214_ex32.htm Edgar Link pending